Skip to content
UroGen Pharma Ltd icon

UroGen Pharma Ltd

URGNStocksBiotechnologyUnited StatesNasdaqUSD

Price

$27.65

Today

-12.9%

YTD

+18.2%

About

UroGen Pharma Ltd is a globally recognised pharmaceutical firm that has a strong presence in markets worldwide and is dedicated to delivering groundbreaking therapeutic solutions to improve patient care. Operating in the rapidly evolving pharmaceutical industry, Urogen Pharma Ltd provides specialised solutions in the urology sector. The company concentrates its efforts on creating treatments for uro-oncological diseases that lack effective solutions. UroGen is best known for its chemotherapy product Jelmyto. Monitor the URGN share price by adding it to your eToro watchlist.

Price chart
Closing price history for URGN (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-20.81
P/S (TTM)5.59
P/B (TTM)-10.83
Market cap$1.36B
Cap tierSmall-cap
Industry avg P/E-5.31

Profitability

Gross margin91.41%
EBIT margin-12.36%
Net margin-1.64%
ROEUnknown
ROA-28.78%

Earnings & Revenue

Revenue (TTM)$250.25M
Revenue growth (1Y)+159.3%
EPS (TTM)-$1.33
Free cash flow$-136.57M
Total debt$196.28M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.16
Employees291
Next earnings2 Mar '27
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

UroGen Pharma Ltd (URGN) | Dirk Kuyken